Categories: News

Next Level Aviation Appoints Louis Kucia as Vice President of Procurement

DANIA BEACH, Fla., Feb. 4, 2026 /PRNewswire/ — Next Level Aviation® (NLA), a leader in the global distribution of used serviceable materials (USM) for all Boeing and Airbus commercial aircraft and associated jet engine platforms, has appointed Louis (Lou) Kucia as Vice President of Procurement.  Mr. Kucia brings 20 years of Boeing and Airbus product line and aftermarket purchasing expertise, in addition to holding an active FAA airframe & powerplant (A&P) license. 

- Advertisement -

In his new role, Lou will be responsible for all USM purchasing activities to stock Next Level Aviation’s Florida warehouse as well as further expanding the company’s vendor base and building a team of buyers underneath him to continue to fuel Next Level Aviation’s impressive growth trajectory.

- Advertisement -

Next Level Aviation® Founder, Chairman and CEO Jack Gordon commented, “We are very excited to have Lou join the team as our new VP of Procurement.  We did millions of dollars’ worth of USM deals with Lou in the early years of Next Level Aviation® while he was on the opposite side of transactions at one of his previous employers, so we are pleased we can finally add him to the NLA team and leverage his impressive analytical and negotiation skill sets to further grow our business.”

- Advertisement -

VP of Procurement Louis Kucia stated, “I’ve had the pleasure of working with Next Level Aviation since the day they launched.  As one of my personal favorite aftermarket business partners in the industry, I’ve watched their success story from the front row for the last 13 years, and joining the team today feels like stepping right into an epic movie, already in progress. Stay tuned!”

- Advertisement -

About Next Level Aviation®
Next Level Aviation® is an ASA-100 accredited, and FAA Advisory Circular 00-56B compliant supplier stocking commercial aircraft/jet engine used serviceable material (USM) for all Boeing and Airbus aircraft platforms and associated jet engines. Next Level Aviation® specifically focuses on stocking USM for the Boeing 737 and Airbus A320 families of aircraft and their associated jet engines, which currently make up about 65% of the global commercial fleet. Founded in March 2013 by Jack Gordon Next Level Aviation® has grown into a top global supplier of commercial aircraft/jet engine used serviceable material. www.nextlevelaviation.net

- Advertisement -

To find out more information or to request additional images, please contact morgane@aerospacemarketing.com.

- Advertisement -

Logo – https://mma.prnewswire.com/media/2367849/Next_Level_Aviation_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/next-level-aviation-appoints-louis-kucia-as-vice-president-of-procurement-302677903.html

- Advertisement -

Recent Posts

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

3 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

3 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

3 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

3 hours ago

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…

3 hours ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…

3 hours ago